
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x).
Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.
Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire.

Monitoring HIV/AIDS in Europe's migrant communities and ethnic minorities

Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions.
Adipose tissue expression of IL-18 and HIV-associated lipodystrophy.
Shared breastfeeding in central Africa.
The use of blood donor data for HIV surveillance purposes
Indinavir increases glucose production in healthy HIV-negative men.
